Study Stopped
The human resources required to start enrollment were not available anymore.
Heat Therapy in Patients With Type 2 Diabetes Mellitus
HEATED
The Effect of HEAT Therapy on patiEnts With Type 2 Diabetes Mellitus (HEATED): Protocol of a Randomized, Two-arm Controlled Trial
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Type 2 diabetes mellitus (T2DM) is a significant burden worldwide. In addition to lifestyle intervention, heat therapy has been shown to be effective in improving glycemic control. To date, there are no randomized, controlled trials investigating the efficacy of heat therapy in T2DM. Our aim is to investigate whether heat therapy with natural mineral water can improve blood glucose status in T2DM patients. The HEATED study is a two-arm, randomized, controlled study. Patients with T2DM were randomly assigned to Group A (bath in 38 ° C natural thermal mineral water) or Group B (bath in thermoneutral water - 30-32 ° C). Both groups participate in up to five interventions per week, representing 50 to 60 heat therapies over the 12-week study. Each intervention lasts 30 minutes, preceded by a medical examination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2022
Typical duration for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2022
CompletedFirst Posted
Study publicly available on registry
February 14, 2022
CompletedStudy Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedApril 20, 2023
April 1, 2023
1.7 years
January 5, 2022
April 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in hemoglobin A1c level
The absolut changes in the hemoglobin A1c from baseline to 12-weeks between the two groups will be compared.
12 weeks
Secondary Outcomes (31)
Change in hemoglobin A1c level
4 and 8 weeks
Change in fasting plasma glucose
4,8, and 12-weeks
Change in fasting insulin
4,8, and 12-weeks
Change in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
4,8, and 12-weeks
Decrease of daily insulin dose
4,8, and 12-weeks
- +26 more secondary outcomes
Study Arms (2)
Passive heating
EXPERIMENTALPatients will be randomized to receive whole-body passive heating via 38°C natural thermal mineral water baths.
Thermoneutral
ACTIVE COMPARATORPatients randomized to the comparator group will dip in thermoneutral natural thermal mineral water (30-32°C).
Interventions
Patients will perform baths in 38°C natural thermal mineral water a maximum of five times per week, over a 12-week period. This will result in a maximum of 60 visits. Each visit will take a maximum of 30 minutes with a physical check-up before and after the bath.
Patients will perform baths in 30-32°C natural thermal mineral water a maximum of five times per week, over a 12-week period. This will result in a maximum of 60 visits. Each visit will take a maximum of 30 minutes with a physical check-up before and after the bath.
Eligibility Criteria
You may qualify if:
- patient with type 2 diabetes diagnosed according to the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) guidelines
- serum glycated hemoglobin (HbA1c) level between 7 and 10% (53-86 mmol/mol)
- signed written informed consent form
You may not qualify if:
- other types of diabetes mellitus
- patients with poor glycaemic control or unstable diabetes
- patients with known serious comorbidity and/ or with advanced macrovascular complications
- active bacterial infection or treatment with antibiotics within 3 weeks
- open wounds or skin lesions
- history of skin-related conditions or sensitivity to prolonged water immersion or exposure to pool chemicals
- severe psychiatric pathology or psychosis
- pregnancy or breastfeeding
- judgment by medical provider that heat therapy/ hydrotherapy poses an undue burden or risk
- participating in other ongoing clinical trials
- heat or balneotherapy in the past 3 months
- morbid obesity (body mass index \> 40 kg/m2)
- steroid treatment
- active autoimmune diseases
- coronavirus disease 2019 (COVID-19) in the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute for Translational Medicine, University of Pécs
Pécs, 7624, Hungary
Related Publications (8)
Sebok J, Edel Z, Vancsa S, Farkas N, Kiss S, Eross B, Torok Z, Balogh G, Balogi Z, Nagy R, Hooper PL, Geiger PC, Wittmann I, Vigh L, Dembrovszky F, Hegyi P. Heat therapy shows benefit in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Int J Hyperthermia. 2021;38(1):1650-1659. doi: 10.1080/02656736.2021.2003445.
PMID: 34808071BACKGROUNDRomeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1771-6. doi: 10.1161/ATVBAHA.111.241869.
PMID: 22815343BACKGROUNDSalas-Salvado J, Diaz-Lopez A, Ruiz-Canela M, Basora J, Fito M, Corella D, Serra-Majem L, Warnberg J, Romaguera D, Estruch R, Vidal J, Martinez JA, Aros F, Vazquez C, Ros E, Vioque J, Lopez-Miranda J, Bueno-Cavanillas A, Tur JA, Tinahones FJ, Martin V, Lapetra J, Pinto X, Daimiel L, Delgado-Rodriguez M, Matia P, Gomez-Gracia E, Diez-Espino J, Babio N, Castaner O, Sorli JV, Fiol M, Zulet MA, Bullo M, Goday A, Martinez-Gonzalez MA; PREDIMED-Plus investigators. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial. Diabetes Care. 2019 May;42(5):777-788. doi: 10.2337/dc18-0836. Epub 2018 Nov 2.
PMID: 30389673BACKGROUNDBrunt VE, Howard MJ, Francisco MA, Ely BR, Minson CT. Passive heat therapy improves endothelial function, arterial stiffness and blood pressure in sedentary humans. J Physiol. 2016 Sep 15;594(18):5329-42. doi: 10.1113/JP272453. Epub 2016 Jun 30.
PMID: 27270841BACKGROUNDHoekstra SP, Bishop NC, Faulkner SH, Bailey SJ, Leicht CA. Acute and chronic effects of hot water immersion on inflammation and metabolism in sedentary, overweight adults. J Appl Physiol (1985). 2018 Dec 1;125(6):2008-2018. doi: 10.1152/japplphysiol.00407.2018. Epub 2018 Oct 18.
PMID: 30335579BACKGROUNDHooper PL, Balogh G, Rivas E, Kavanagh K, Vigh L. The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes. Cell Stress Chaperones. 2014 Jul;19(4):447-64. doi: 10.1007/s12192-014-0493-8. Epub 2014 Feb 13.
PMID: 24523032BACKGROUNDHooper PL. Hot-tub therapy for type 2 diabetes mellitus. N Engl J Med. 1999 Sep 16;341(12):924-5. doi: 10.1056/NEJM199909163411216. No abstract available.
PMID: 10498473BACKGROUNDSebok J, Edel Z, Dembrovszky F, Farkas N, Torok Z, Balogh G, Peter M, Papp I, Balogi Z, Nusser N, Peter I, Hooper P, Geiger P, Eross B, Wittmann I, Vancsa S, Vigh L, Hegyi P. Effect of HEAT therapy in patiEnts with type 2 Diabetes mellitus (HEATED): protocol for a randomised controlled trial. BMJ Open. 2022 Jul 12;12(7):e062122. doi: 10.1136/bmjopen-2022-062122.
PMID: 35820741DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Director of the Centre for Translational Medicine at University of Pécs
Study Record Dates
First Submitted
January 5, 2022
First Posted
February 14, 2022
Study Start
May 1, 2022
Primary Completion
January 1, 2024
Study Completion
June 1, 2024
Last Updated
April 20, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share